Market Update – January 28, 2008

Weekly Results:

S&P 500 -.19% NASDAQ -.88% Russell 2000 +1.18% and MSCI Emerging Markets -.90%

Big Picture :

Plenty of action in a holiday shortened week. A sharp global sell-off, Federal Reserve intervention and approval of a stimulus package all caught the attention of mainstream media. Beyond the growing concern of "recession" and panicked selling, there are plenty of factors contributing to market performance. Mainly, company earnings continue to shape investor outlook. This week is jam-packed with earnings results from several companies that can give clues to emerging themes. Also, outside of typical investment noise, last week's actions should not be surprising given the current junction of the business cycle, credit concerns and a pending trend shift.

Volatility and Trend Shift

As many investors watch their portfolio fluctuate, once again it reminds us of the power of volatility, or at least it showcases the importance of watching movement in the VIX (volatility index). More so, on a relative basis the last few years were less turbulent in a period of a bullish uptrend. For example, the index is up nearly 300% since December 2006.

Now, a trend shift is upon us, following a multi-year upside move in commodity based and emerging market themes. Last week, demonstrated a historic like market response; highlighted by wild swings in global markets. As fear continues to build, it forced the Federal Reserve to take a decisive and aggressive approach in cutting rates.

Portfolio Management:

Sentiment remains at extreme bearish levels, which suggests that markets are poised for mean reversion. At the same time, current macro condition leave uncontrollable doubts leading to uncertainty. Therefore, investing in quality ideas is critical. Especially, when expectations are relatively high following recent bullish run. Nonetheless, from a cycle perspective, investors can seek bargains in innovative based themes.

ACTIONABLE IDEAS:

Technology:

Technology is showing signs of regaining leadership following recent corrections. Again, stock specific selection can create better rewards, especially if earnings are above expectations. Simply, valuations for most names are cheap. Plus, the market cycle favors an upside moves in select areas.

CREE (Cree Inc): Upside move continues with strength in its relative strength especially in the past 3 months. Following a solid strength, plenty of upside catalysts including environmental concerns, and demand for efficient energy use. In terms of upside potential, stock is far removed from all-time highs of $100.

SY (Sybase): Profits continue to rise as management delivered to its shareholders. Accumulate as stock stabilizes between $27-25 ranges. Longer-term outlooks are promising.

EMC (EMC Corp): Technical pattern is attractive with a buy point at $16. Fundamental drivers include ownership of VMC (VM Ware), a leader in providing efficient products for IT servers. In addition, EMC's other business units are relatively cheap on valuation basis.

Healthcare:

ECLP (Eclipsys): Company should benefit from growing demand for IT healthcare. Near-term entry point is attractive around $24.

BLUD (Immucor): Reaching oversold levels around $28, a major support level. Analyst have lowered estimates which can create an upside surprise. Overall, fundamental are intact and weakness can create buying opportunity.

MACRO LEVELS:

Crude: Consolidating between $98-88 in the past few months. The commodity is searching for an upcoming catalyst after pausing at $100.

Gold: Once again reaching all-time highs. An explosive 43%+ run since summer lows. Again, investors are rushing for safety following credit concerns.

US 10 Year Yield: Inversely correlated to Gold prices. Nearly a 35% decline since summer highs of 5.20%. Last few days are showing a bottoming potential near 3.28%.

DXY (Dollar Index): Following sharp declines in the past few years, interestingly the index has not made new lows since November 26, 2007. Once again, a 3 month pause appears like a trend reversal. Nonetheless, bearish view on the US Dollar is reaching extreme levels.

FXI (China 25 Index): Attempting to stabilize after declines after peaking on October 31, 2007. Currently, trading near 200 day average. These levels are worth watching to gauge if buyers are ready to reenter.

S&P 500: Next major resistance level is at 1400 followed by1450. Technical indicators are deeply oversold and suggest a recovery. Index is 12% removed from 200 day moving average.

Market Outlook – January 22, 2008

Weekly Results:

S&P 500 -5.41% NASDAQ -4.09% Russell 2000 -4.47% MSCI Emerging Markets -7.46%

Big Picture:

An indecisive Federal Reserve, confused investor community, peaking market, investor panic and unraveling of credit risk resulted in a negative week. In short, markets don't like uncertainty.

In regards to the Federal Reserve actions here is one view below:

"Why would anyone borrow money if they know rates are going to be lower in the future. If you're going to cut rates, do it. If you're not, let the market know that you're not." Bespoke Investment Group.

Earnings and Broad Markets:

As usual, earnings season provides a reaction to company specific stories. Much of trader responses are based on results of the actual vs. expectations. At this junction, downside estimates and pessimistic outlook set the market tone. There is a growing agreement of a bleak outlook and less confidence about the future. Nonetheless, Wall Street analyst estimates appear too high entering earnings season. "At year end the consensus estimate [for S&P 500] was approaching $105. A more likely expectation is $90 to $95 for 2008" (1/14/2008 -Analytic Services). This is not surprising given the positive market response in the past few years.

Along with earnings, the Macroeconomic conditions remain the cornerstone of participants concerns. At this point of the cycle, the bullish run since 2003 is being severely tested. As the unraveling process continues, most value investors are gearing up for buying opportunities. Meanwhile, recent breakdowns signal a confirmation of bear market declines. On that note, current sell-offs begs the question of key technical ranges. The next major support levels are near lows reached in summer 2006(S&P 1260 NASDAQ 2000).

Sensitive issues:

Once again, investor sentiment is lopsided with fear. Even for bears the uneven sentiment makes it questionable to add to short positions. Talks of stimulus package might create near-term optimism but for the most part investors are skeptical. The credit crisis continues to plague both fixed and equity markets. Despite being deeply oversold, earnings for financial companies appear far removed from a bottom. For example, the Bank Index (BKX) is down 37% from highs reached on May 7, 2007. During that period, several recovery attempts have failed sharply including last week. In short, there is a desperate need for an outside catalyst but overall impact is uncertain.

Rotational opportunities:

There are actionable ideas and themes to consider in a period of sharp declines. Generally, there is an inclination to take a defensive stance at times of negative market returns. Nonetheless, Innovation based themes such as Healthcare and select Technology are demonstrating relative strength. These are two themes that were not cycle leaders from 2003-2007. As turbulence lessens, few areas are worth a closer look for bargains.

Rotation opportunity lies ahead as global participants trim exposure in emerging markets, commodities and energy related groups. For example, FXI (China 25 Index) is down nearly 34% since October 2007. Following a tremendous upside explosion from, "bubble-like" levels, Global indexes continue to retrace.

Short:

Emerging Markets (10%), Crude/Energy (15%), and Financials (20%).

Long:

Technology (35%) and Healthcare (25%)

Chart attached below.

Stock Specific Ideas:

Staples:

WMT (Wal-Mart): Outperforming on a relative basis in the past 4+ months. Attempting to break out from multi-year range $44-48.

Technology:

AMAT (Applied Materials): After setting lows on January 11, early signs of a recovery. Management continues to make changes and positive order flow can spark a turnaround. Major support at $16.

EMC (EMC Corp): Approaching key support level at $16. Attractive entry point despite mixed earnings expectations. Overall, growth from VMWare , established customer base, and barrier to entry in its core business contributes to a positive outlook.

BRCM (Broadcom): Despite a heavy broad market sell offs, long-term outlook remains positive. Growth in the cellular market and upcoming product cycle bodes well for sales. Finally, stock is deeply oversold and valuations are relatively cheap.

CREE (Cree Inc): Trading within a range between $24-26. Fundamentals are positive driven by Light-Emitting Diode [LED] technology. Despite near-term speculation, long-term outlook is promising.

Healthcare:

GENZ (Genzyme): Prospects of growth looks very promising. Solid product pipeline and increasing revenues contribute for a sustainable run. Add on pullbacks closer to $75.

Dear Readers

The positions and strategies discussed on MarketTakers are offered for entertainment purposes only and are in no way intended to serve as personal investing advice. Readers should not make any investment decision without first conducting their own thorough due diligence. Readers should assume the editor holds a position in any securities discussed, recommended or panned. While the information provided is obtained from sources believed to be reliable, its accuracy or completeness cannot be guaranteed, nor can this publication be, in any way, considered liable for the future investment performance of any securities or strategies discussed.

Market Update – January 14, 2008

Weekly Results: S&P 500 -.75% NASDAQ -2.58% Russell 2000 -2.35% MSCI Emerging Markets +.17%

Broad Market Outlook:

A tense period for investors as discussions of recession, rate cuts and fear dominate headlines. Not to mention, a sluggish stock market performance to start the year. That said, we are approaching extremes in investor sentiment. Fear is clearly visible in these markets. Put/Call ratio is at the higher end of historical range. In terms of investor sentiment, percentage of bears increased by 7%. Conversely, bullish readings declined by 23%. (Source: American Association of Individual Investors). Once again, along with rising volatility the sentiment readings are lopsided in one direction.

As we enter earnings season, stock behavior will be linked to stock specific results from fourth quarter. Recently, analyst downside revisions continue to have a negative impact. In fact, year over year growth expectations have been revised down by 20%. (Birinyi Associates, Inc). This illustrates extreme pessimism, which generally results in cycle lows. The next few weeks will reveal if the actual results are worse than the growing lower expectation.

Financials remain a key topic of interest for both buyers and sellers. Buyers are seeking to purchase at these depressed levels. Meanwhile, sellers are waiting to place additional bets on downside moves. M&A announcements, write-downs and pending earning announcement should produce eventful results. Importantly, speculation on Federal Reserve rate cuts and slowing economy will dictate a recovery in the sector.

Staying on Course:

Sticking to year-end goals, rotation into innovation can create opportunities. In fact, healthcare is leading most groups in staying ahead. For example, XLV (Healthcare Sector ETF) is up 5% versus the S&P 500 -4.6% in 2008. The sector remains favorable on a stock by stock basis.

Stock Specific Ideas:

HEALTHCARE:

GENZ (Genzyme): Strong performance in the past 3+ months. Solid revenue growth and fundamentals have given stock further boost. Add on pullbacks closer to $72-70.

XRAY (Dentsply Intl): Although extended in the near-term, long-term uptrend in tact. Global dental demand should contribute to further upside gains. Trend remains positive $40.

Other ideas include: TECH (Techne), MATK (Martek Bio), BLUD (Immucor) and PPDI (Pharmaceutical Products).

In the meantime, the sell-offs in the NASDAQ (down 8% year to date) is creating more investor panic in technology themes. Once again, picking bottoms is not an easy task. There are bargains out there in the marketplace especially in quality names. Overall, valuations are near levels reached in 2002 bear market lows. Following earning results, odds for entry points should become more favorable.

MACROS:

Crude: Further consolidation between $100-90 ranges. Near-time momentum is extended suggesting pause/downside move.

Gold: Trading at all-time highs. Since late June 2007, the commodity is up nearly 40%.

US 10 Year Yield: Attempting to bottom between 3.75-3.79%. Yields have declined 29.4% since summer 2007.

S&P 500: Trading at key support level near 1400. Watch for August lows of 1370 as a gauge of investor's views.

EEM (Emerging Markets): Above 200 day moving average which suggests an exiting uptrend. In the past 2+ months, upside move is pausing between 144-152.

Market Update – January 7, 2008

Weekly Results:

S&P 500 -4.39% NASDAQ -6.43% Russell 2000 -6.71% and MSCI Emerging Markets 147.41 -3.36%

Despite a holiday shortened week, S&P 500 fell more than 4% to start the year. Perhaps, this further confirms the existing uncertainty and growing pessimism. Once again economic data is the main focus for investors. Last week produced weak economic results in labor, housing and factory sectors. Friday's non-farm payroll triggered "panic-like" sell offs. For the most part, declines are not surprising given the junction of the market cycle.

Investor sentiment is overly depressed along with excessive negative coverage in the mainstream media. For example, last week Volatility index rose by 18% and put/call ratio increased by 16% --again indicating more fear. Stock market continues to reflects weakness since mid 2007 which has turned near term indicators into oversold territory. That said, being a bear is heavily fashionable but dangerous when too extreme. Nonetheless, expect sideway swings in the weeks ahead.

In period of uncertainty and confusion, it is helpful to list out key points which can serve as a road map.

First quarter themes:

• Markets are pausing from muli-year bullish run
• Growing probability of a trend shift especially in an election year
• Take advantage of rotational opportunity
• Accumulate quality areas for cheaper value mid year
• Credit risk themes are yet to be resolved leaving most financials vulnerable
• Reactions to Economic data will dictate investor sentiment
• Expect volatility to increase and remain above average levels

Actionable steps:

Trim risk exposure in previous cycle winners. Such as Small Cap, Emerging Markets and Commodity based themes. After a strong 5-7 year cycle, in these areas the risk/reward outlook is not as attractive.

In the upcoming months, investors will have the opportunity to build smaller position in investment ideas. At this point, buying long ideas might not offer a timely entry point; the 1^st quarter is a challenging period, therefore raise cash or slowly accumulate stocks in innovative related groups.

Stock Specific Ideas:

Technology:

CREE (Cree Inc): Early signs of long-term recovery at current levels. Stock remains timely despite broad market sharp-sell off. Competitive edge with efficient product in and technology such as LED (light emitting diode) creates opportunities for long-term investors. In fact, investors rushed to buy as the stock fits the "green technology" theme.

PAYX (Paychex): Deeply oversold in the near-term. Following a 7+ year of price consolidation, stock is attempting to recover.

Healthcare:

BLUD (Immucore): Longer-term chart pattern is attractive. Fundamentals overall are positive more detail in earnings this week. Nonetheless, outside of major surprises stock is appealing at current levels. $32-30.

TECH (Techne): Solid 6+ month relative performance for the maker and manufacture of biotechnology products. Recent buybacks are driving stock price higher and company is relatively cash rich. That bodes well in the current environment.

PPDI (Pharmaceutical product): Strong relative performance versus the broad market in the fourth quarter of 2007. Revenues are increasing and stock price is consolidating between $40-42 ranges. That should set up attractive entry point.

Macro Review:

Crude: Uptrend in tact. Intra-day high of 100 (January 3^rd) remains next key resistance level. Index is becoming overbought in the near-term.

Gold: Making new highs following 2+ month consolidation. Explosive upside move since mid 2007.

US 10 Year Yields: Down over 28% since June 2007. Nearing lows from November at 3.79%. No evidence of a turnaround at this point.

S&P 500: Consolidating in a tight range (1540-1400), further illustrating a pause. From a short-term perspective, index is approaching oversold levels near 1400 followed by 1370. Expect aggressive short-term traders to place long bets at these levels.

EEM (MSCI Emerging Markets): Attempting to bottom from recent declines. Currently in the process of a 4+ month of sideway trading. Look for a key inflection points between $136-144.

Dear Readers

The positions and strategies discussed on MarketTakers are offered for entertainment purposes only and are in no way intended to serve as personal investing advice. Readers should not make any investment decision without first conducting their own thorough due diligence. Readers should assume the editor holds a position in any securities discussed, recommended or panned. While the information provided is obtained from sources believed to be reliable, its accuracy or completeness cannot be guaranteed, nor can this publication be, in any way, considered liable for the future investment performance of any securities or strategies discussed.

Market Update: December 31, 2007

Weekly Results:

S&P 500 +1.26% NASDAQ +1.27% Russell 2000 +.55% MSCI Emerging Markets +2.28%

Although not many actionable ideas, it is a good time to ask the following questions:

Do your portfolio holdings contain sustainable ideas for 3-5 years ?

If not, ask yourself what is your upside expectations?

Finally, what areas are worth exploring for emerging ideas?

Does your portfolio match your goals and reflect your market views?

Perhaps, answering these questions can springboard a fruitful New Year.

Looking ahead:

The status of the US economy will take center stage in the mainstream media as we head into an election year. That seems to be one of the few high conviction ideas for 2008. Perhaps, increase in volatility ranks second. Also, heavy sell-offs can mark a period of trend shift. In general, excessive pessimism creates "bottoms" for new cycle themes. Finally, it would be a wise move for investors to leave a category titled "unfathomable". Although, not actionable, it's important to recognize and react to least expected events.

Econ Talk:

Actions from Federal Reserve, slowing economy, concerns of housing and stabilization of financial services can dictate market directions. Expect plenty of opinions, prognoses and data focus. Nonetheless, the basic takeaway is that we are transitioning away from a period of "easy" money. At this point, policymakers will attempt to manage consequences of this cycle rotation. The interesting (relevant) part is watching investors react to ongoing economic data.

Investor Sentiment:

Volatility increased significantly in 2008. VIX remains above 20, which indicates investor anxiety. Fear is caused as investors anticipate a trend shift. Currently, the bearish sentiment (according to AAII) is elevated and reaching depressed levels. Therefore, an upside move or relief rally in the near-term should not be surprising.

Chart attached below.

Sell Offs/ New Opportunities:

There are opportunities to profit from sell-offs assuming significant declines in the first part of 2008. The S&P 500 is up 92% since 2002 as the bullish run is intact. That said, it is not surprising to see near-term corrections. For less aggressive investors, mid 2008 can offer early entry points to beaten up stocks. Again, areas of interests are in innovative related themes. Groups include Technology, Media, communications and select Healthcare.

Financials:

Once again the upcoming year, can be a difficult period for Financial Services. Certainly, not a pleasant way to starts a New Year but several factors lead to this assumption. Fundamentals of large financial institutions remain weak, credit card defaults are rising (26% last month), foreclosures are increasing and more unraveling of existing credit risk.

Now, a turnaround bet is too early at this point. Aggressive investors can claim to see "value" at these levels, but the Macro environment is not favorable. In fact, until volatility shows stabilization the risks can outweigh rewards. In addition, attempted bail outs, outside intervention and dependency on Federal Reserve policy create short-term optimism. Therefore, investors have to assess short-term catalysts versus long-term recoveries.

Stock Specific Ideas:

Media:

DTV (Direct TV): Attempting to bottom around $23. Growth in HD TV bodes well for overall fundamentals.

CBS (CBS Corp): Nearing key support level at $26. Oversold, following a disappointing 3^rd quarter. Stock is cheaper relative to its group, fundamentals are not as negative as price suggests. As investors adjust their expectation, expect an upside move.

Telecommunications:

VZ (Verizon): Long-term recovery is intact. Wireless results are promising, remains at a buy point ($44-40 range).

Healthcare:

GENZ (Genzyme): Stock price demonstrating leadership. Although, slightly stretched in the near-term, product remains as a positive outlook.

BLUD (Immucor): Fundamentals are solid. Risk/reward for an upside move is attractive for the maker of blood bank systems.

Technology:

CREE (Cree Inc): Recovering from oversold levels. Recently, innovative technology is giving investors some confidence. That can be a catalyst for an upside move from the $25 range.

ORCL (Oracle): Strength continues to develop as the stock price is finishing the year on a strong note. A rotation into technology and larger cap names leads to a favorable outlook for ORCL. Technical pattern and fundamental outlook remains solid. Accumulate between $20-22 ranges.

HTCH (Hutchinson Tech): Attempting to break-out from multi-year trading range. Company continues to efficiently control its cost while improving gross margins.

HAPPY NEW YEAR!!!!

Dear Readers:

The positions and strategies discussed on MarketTakers are offered for entertainment purposes only and are in no way intended to serve as personal investing advice. Readers should not make any investment decision without first conducting their own thorough due diligence. Readers should assume the editor holds a position in any securities discussed, recommended or panned. While the information provided is obtained from sources believed to be reliable, its accuracy or completeness cannot be guaranteed, nor can this publication be, in any way, considered liable for the future investment performance of any securities or strategies discussed.

Market Reflection - December 24, 2007

Weekly Results:S&P 500 +1.13% NASDAQ +2.1% Russell 2000 +4.2% MSCI Emerging Markets+.35%

Given the recent market behavior, most participants are ready for 2008. Especially with a sluggish December which appears to finish belowhistorical average. This wraps up a rollercoaster year which witnessed asurge in Crude prices and an ongoing upside move in Emerging Markets. On the other hand, 2007 demonstrated a depleting US Dollar and breakdown inFinancials triggered by a credit crisis. Not to mention, accelerated boom in China, decline in yields and a clear increase in volatility.Interestingly, the market dynamics kept the bulls and bears active.Overall, a 'wild' welcome for Ben Bernanke, as his first year chairman of the Federal Reserve. All added up to an eventful year.

Looking ahead, most cycle studies suggest a trend shift is upon us.Visible trends in the past 5 years are subject to change. Primarily, apause in an explosive bull market for Emerging Markets, Crude, Commodity related themes and Commodity linked Currencies. Conversely, a bearishperiod for US Large Cap, US dollar, and innovative based industries.Now, to clarify a trend shift can mean opportunity while others call ituncertainty. For example, emerging strength in Large Cap Growth developing. Again, select technology and healthcare can be rewarding forstock pickers. Unfortunately, there are more issues to be resolved for the broad markets. Regardless, additional sell-offs can set betterentry points.

During this part of the year, it is customary for the analyst communityto write about thoughts for the next year. In fact, most pundits have stated that a weak and slow year is ahead of us. Let us not forget, thatswitching the calendar does not alleviate on-going market trends.Meanwhile, there are themes that developed in 2007 that have yet tomaterialize. For example, media sector remains depressed, most US healthcare is stagnate and large cap tech is showing early signs ofleadership.

Now a New Year is a fresh start but old investment disciplines are yetapplicable. As stated above a cycle shift in leadership offers intriguing times for money managers. Expect periods of "trendless"markets which will challenge investor's conviction levels. At the sametime additional panic selling can carve out bottoms which can be neglected by fear. Perhaps this New Year offers a buying opportunity for long-term investors despite near-term concerns.

Happy Holidays!

Market Thoughts - December 17, 2007

Weekly Results: S&P 500 -2.44%DJIA -2.10% NASDAQ -2.60% Russell 2000
-4.02% MSCI Emerging Markets 151.36 -5.16%

A negative finish following rate cuts by the Federal Reserve. 10 trading
days left as participants look ahead to 2008.

In the upcoming year, mainstream media will continue to focus on the slowing
economy and a potential recession. This is understandable, as we head into an
election year. Most of 2007 unraveled the fundamental weakness in Financial
Services. Some value managers are seeking to pick bottoms in Banks driven by
Central Bank's decision to inject liquidity into the financial system. Overall credit risk is not fully complete and picking bottoms, in general, is a difficult task. Finally, investor's willingness for higher risk tolerance is questionable – primarily in a declining sector. Yet again, the duel between optimist and realist will be determined in the weeks ahead.

As for the stock market, December has not proven to be bullish as history suggested.
In fact, yearly highs reached in October 2007, seem far removed
to eclipse as we are left with few trading sessions. For example, the S&P
500 is 7% away from yearly and all-time highs. Let's not forget, the S&P 500
index is up over 86% since March 2003. Therefore, recent market declines are
viewed as a pause (top) in the current market cycle, especially among the
bearish crowd.

Volatility is poised to go higher in a period of uncertainty. Since October
11, VIX (Volatility Index) has shown signs of bottoming and is up 44%. At
this point, VIX is set to rise again following short-term declines. The
increase in volatility showcases that there is fear in the marketplace.
Index is above 20 for several weeks which historically suggests increased investor anxiety.
Finally, this turbulence signals a shift in market leadership.

Actionable Ideas:

Despite worries, concerns and additional noise there are stock specific
opportunities as usual. The challenge is timing just as much as it is
identifying the right catalyst. Past 4 + years, cycle leaders were mainly in
commodity and emerging markets led an upside rally. Now, the cycle is
poised for a trend shift into developed markets (US and Europe) and
companies focused on "innovation".

For example, Growth oriented ideas are showing strength especially in Large
Cap. Healthcare and Technology are the key "growth" sectors and appear
favorable. Clearly, traditional value (such as: Banks and Energy) are poised
for a consolidation and lack relative strength. In fact, Large Cap Growth is
up 12% year to date and is the best performing style.

STOCK SPECIFIC IDEAS:

Technology:

FFIV (F5 Networks): Deeply oversold and offers value at current levels.
On-line video growth bodes well for the company as it maintains its
completive edge. Stock is 28% removed from 200 day moving average.

PAYX (Paychex): Strong consistent revenue growth yet stock is extremely
oversold. A leader as a payroll provider and no debt in the balance sheet,
upside promises are attractive. Again, value investors can enter long
positions around $38.

Staples:

ADM (Archer Daniels): Relative strength intact. Remains at a buy point, as
companies' agricultural exposure offers further growth. Current price range
offers buying opportunity.

Healthcare:

GENZ (Genzyme): Positive fundamentals and a technical breakout since October.
Buy on pullbacks. Above $70, existing trend is intact.

Telcom:

VZ (Verizon): Shares remain depressed as stock attempts to bottom.
Analysts expect further weakness, therefore there is less downside surprise
ahead. Accumulate between $44-42.

Macro Levels:

Crude: Consolidating between $90-95 ranges. In the fourth quarter, on
three occasions investors have kept the commodity above $90. Noticeably,
buying pressure is slowing down.

Gold: Near-term pause after an explosive 4+ month upside move. Trading
within a range $820-780.

US 10 Year Yield: Sharp recovery from November lows. Bottoming at current
levels (4.00-4.20%).

US Dollar (DXY): Similarly, bouncing higher from November lows. Attempting
to hold above $77. Early signs of recovery.

S&P 500: Slightly extended in the near-term. Next major support at 1440.

EEM (Emerging Markets):Pausing in the last 3+ months. Recently, Volume
has declined and buyers await pullbacks to add. Also, index is far removed from 200 day moving average, which suggests additional near-term declines.

Market Thoughts : December 10, 2007

Weekly Results:

S&P 500 +1.59% NASDAQ +1.70% Russell +2.31% MSCI and Emerging Markets +3.87%

Policy intervention and pending rate cuts by the Federal Reserve contributed to a positive week. Recent discussions of "bailouts" generated optimism. Headline news (noise) on 'mortgage relief' forced bears to exit in the already depleted financial sector. Sadly, the plan can generate near-term uproar but sustainability remains doubtful.

Following the Thanksgiving weekend, the S&P 500 is up 7.2% and 6.1% for 2007. Seasonally, odds are favorable for an upside move especially following a period of high pessimism. Also, a sharp decline in volatility (VIX Index) points to oversold conditions and less downside turbulence. Macro indicators are showing signs of early trend reversal. For example, US dollar is up more than 2% since November 26. At the same time, Crude is down 11% from yearly highs. Although, short sighted, current dynamics set the stage for a broad market rally.

This market requires one to differentiate short and long-term ideas. In other words, it is important not to confuse trading vs. investing. With 15 trading days left in the year, some areas are worth a look for a technical rally. On the other hand, long-term bargain hunters can seek "value" especially in groups poised for cycle leadership. Finally, for those looking to profit on declines, patience can be more rewarding well into 2008.

Near-term: (3-6 weeks):

Oversold consumer themes such as, Banks, Lenders, Retail and homebuilders, led a sharp rally in the past few days. As expected, there are higher beta themes and yearly underperformers are poised for a year-end rally. For example homebuilders increased 10% for the week. It is not surprising to see a trading bounce given sluggish performance in the past 2+ month.

Intermediate-Term: (6-9 months):

In looking ahead, attractive ideas should emerge from Technology and Healthcare. A rotation out of commodity themes can rotate to innovation based companies. Large Cap companies are relatively "cash-rich" and can benefit in a slowing economy. For example, AAPL (Aapple) carries a $15.4 billion cash position which is ahead of Microsoft. That bodes well for future innovation within the sector. Of course, pending price declines can offer better entry points.

Also, consumer staples present exposure in defensive themes mainly in food related areas. For example, Wal Mart (WMT) and Costco (COST) are up over 15% since mid November. Expect this momentum to carry over for upcoming quarters ahead.

Stock Specific Ideas:

Media:

DTV (Direct TV): At a buy point near $24. Fundamentals are solid as company continues to increase its market share.

Healthcare:

BLUD (Immucor): Consolidating near $30. Appealing entry point following recent declines. Also, a leader in automated instruments for blood typing.

Technology:

BRCM (Broadcom): Attempting to bottom between $26-28 range. External factors are keeping buyers on the sideline. Overall fundamental strength remains intact.

SWKS (Skyworks): Relative strength is favorable. Increase in gross margins, and promising outlook in communication area, sets the stage for a buying opportunity. Accumulate on any pullbacks.

GLW (Corning): Stock price is oversold from a long-term perspective. Sales growth looks promising in the company's display and communication segments.

Staples:

CQB (Chiquita Brands): Uptrend intact. Accumulate on pullbacks closer to $18. Favorable tariff results in Europe can trigger additional buying. In addition, basic fundamentals are net positive.

ADM (Archer Daniels): Low p/e ratio suggests attractive valuation. Technical pattern is positive given recent breakout above $38. Finally, attractive cycle for agricultural related themes.

Market Update: December 3, 2007

Resurgence of optimism as broad markets finished higher.

Weekly Results:

S&P 500 +2.81%, NASDAQ +2.48%, Russell 2000 +1.69% and MSCI Emerging Markets +4.55%.

In terms of psychological levels, Crude decreased below $90 and the US 10 Year Treasury Yields broke below 4%. Of course, longer-term trends are in tact for the most part. At the same time, volatility retraced as it closed down 10% for the week. Importantly, participants are paying much attention to upcoming rate cuts by the Federal Reserve. Speculations are creating a bullish bias, following a surge in investor anxiety.

After heavy selling in equity markets, most indexes are poised for a near-term recovery. Especially, groups and stocks that underperformed year-to-date, should witness upcoming relief. That said, weakness in Financials, housing and consumer related themes is not alleviated from further fundamental risks. In other words, it's vital not to confuse trading with investing.

As for the next four weeks, some historians argue that a bad November leads to a profitable December. In the last 30 years, December has been the best performing month 24 times. On that note, higher beta themes offer buying opportunities. Otherwise, given the macro uncertainty, a stock by stock selection can be more favorable approach.

MACRO LEVELS:

Crude: Early signs of topping after peaking at $98 on November 23. Next key support level near $84 as long anticipated declines begin to materialize

Natural Gas: Up 39% since August 27 lows- showcasing a defined uptrend. Short-term pause with key support at $7.

Gold: Expect prices to fall in the near-term. That said, long-term uptrend is intact.

US 10 Year Yield: Attempting to bottom between 3.80-4.00%. Although deeply oversold policy by the Federal Reserve takes precedence as rate cuts are accepted by consensus.

S&P 500: Index is 6% removed from all-time highs set in early October. 1480-1520 are key levels to watch for the next few weeks.

EEM (Emerging Markets): Consolidating between $144-160.Poised for sideway trading action for upcoming weeks.

Stock Specific:

Utilities:

Appealing sector for those looking to protect annual gains or avoid market fluctuation. Also, several names offer attractive entry points. Ideas includes: EP (El Paso Corp.), AYE (Allegheny Energy) and MIR (Mirant Corp).

Staples:

ADM (Archer Daniels): Stock price is attractive at current levels. Add on pullbacks closer to $35. Growth in global grain demand should benefit ADM. Favorable entry point at current levels.

Media:

DTV (Direct TV): Remains at a buy point. Fundamentals are solid as company continues to create growth. Accumulate above $22.

Healthcare:

GENZ (Genzyme): Positive momentum as stock is approaching all-time highs ($76.90). Overall fundamentals are promising and investor demand should increase.

Technology:

Going into the year-end, the technology sector offers mostly trading ideas. Long-term fundamentals are unclear, despite solid earnings growth in the past year. Perhaps, investor expectations are too high. Nonetheless, there are opportunities in the sector.

Last weeks ideas which are relatively timely: GLW(Corning), SWKS (Skyworks), PAY (Verifone), SYNA (Synaptics) and ORCL (Oracle).

Additional ideas below:

BRCM (Broadcom): Deeply oversold while attempting to bottom near $26.23. In looking ahead, promising outlook in the wireless handset market which can serve as a catalyst for an upside move.

PLT (Plantronics): Sitting at key support at $26. Leadership in core headset business can produce an additional lift.

Market Update -11-26-2007

Market Update -11-26-2007

As we come down the stretch in 2007, investors seem far removed from reaching clarity. In other words, most signals, sentiments and behaviors are becoming more confusing. At least for those attempting to connect the dots and construct a winning portfolio. Perhaps, it is not surprising given a depleted credit market, beaten down US Dollar and elevated commodity prices.

Thematically, these existing trends appear "crowded". At this point, it might not be wise to pile on existing trends. In recent weeks, the most accepted trade is short dollar and long energy. Amazingly, a contrarian bet is not as unpopular as one would think. (Long Dollar/Short Crude) In fact, the short interest for energy are at peak levels. Meanwhile, many technical traders have unsuccessfully attempted to call a bottom on the dollar. Nonetheless, the multi-year trend for the Dollar and Crude remains intact. Evidently, predicting an inevitable trend shift is a monumental task for market participants.

On a similar line of thinking, value investors who accumulated financial, consumer, housing and mortgage related "bargains" are feeling pain. The crisis in the credit markets has not reached the late innings as hoped by many. This is an illustration of additional bad news ahead for financials. Recent minutes from the Federal Reserve showcased more concern for housing. Importantly, the FOMC statement suggested a bias for pending rate cuts. Overall, a slowing economy is a topic that should influence business spending, investor demand and media coverage.

Picking Spots:

Once again, a broad market view is not enough to produce desired returns. Also, betting on macro directions alone does not answer the stock specific questions. That said, plenty of issues to consider and probably best to examine sector by sector.

Healthcare:

BLUD (Immucor): Fundamentals are solid as seen by increase in revenue for 16 straight quarters. Technical pattern also supports an upside move for the maker of blood bank systems.

GENZ (Genzyme): Leadership intact in the biotechnology group as seen by its unique products, solid earnings and positive momentum. Current levels offer opportunity to accumulate especially given recent declines from October highs.

Technology:

For upcoming weeks, few areas offer potential for a year-end rally, especially stocks with higher beta. Also, the sector displayed a net positive Q3 results. Given the challenging period for stock specific calls, it might be favorable to focus on those showcasing relative strength. Finally, a rotation into Large Cap Growth should continue to benefit the sector. Stock specific ideas below:

GLW(Corning): Stock is nearing a key support level at $22. Importantly, company is back to profitably, especially in its core business of glass and ceramic products. Expansion in telecom and cable creates further catalyst for price movement.

SWKS (Skyworks): Appealing entry point near $8. Growth in smart phones positively impacts companies' sales growth.

PAY (Verifone): Use near-term consolidation as buying opportunity. First entry point near $42-44 range.

SYNA (Synaptics): Continues to demonstrate relative strength. Growth in mobile computing and electronic devices creates upside potential. Accumulate on any weakness.

ORCL (Oracle): Remains at a buy point near $20. Earnings and sales are ahead of estimate. Company should create growth by acquisition. Finally, product mix is relatively strong, suggesting a sustainable recovery.

Telecommunication:

VZ: (Verizon): Sitting at key support level $42, as stock attempts to bottom. From a long term perspective, Verizon's low turnover and high margins bodes well. Especially, heading into a period where investors demand shares of "cash rich" companies.

Media:

TWX (Time Warner): Following a sluggish relative performance in the past four years, TWX is setting up for a recovery. Growth opportunity lies in cable and film operations. Deeply oversold and favorable for upside move at $16.

Financials:

Maintain short positions on Lenders and Small Banks. At this point, the sector is set up for a near-term recovery. Nonetheless, niche areas are at cycle highs and face further fundamental risk.

Short Ideas: FED (First Federal), DSL (Downey Financial) and WFSL (Washington Federal).

Weekly Update: November 19, 2007

Weekly Results: S&P 500 +.34% DJIA +1.03% NASDAQ +.35% and MSCI Emerging Markets -1.38%

Despite negative sentiment, major indexes finished slightly positive for the week.

Participants are waiting for further clarity on economic outlook and recent sell-offs.

Broad Markets:

It is important not to confuse talks of "recession" with stock market collapse. In fact, the majority of money managers stay focused on implementing their investment strategies rather than react to market sentiment (Investment Advisor 9-2007). On that note, broad markets are shaping up for a year-end recovery. Recent declines offer bargains for those seeking attractive valuations. Historically, we are approaching a favorable season for equity markets, especially in the third year of a presidential cycle. That said, the next few weeks should determine the conviction level of buyers.

At the same time, these are periods of uncertainty following a bullish run in the past 4+ years. S&P 500 index is almost 8% removed from all-time highs set on October 11, 2007. Currently, the index is at short-term buy point between 1440-1420 ranges. If further declines below theses levels, expect further discussions on a potential cycle peak.

Credit Concerns:

Credit risk continues to linger, especially from a fundamental point of view. Select Lenders and Small Cap Banks remain vulnerable. On technical basis, financials are becoming oversold as optimist step in. Nevertheless, a sharp turnaround in the sector can produce trading profits but not sustainable investment ideas. Not to mention, that some companies are facing severe financial crisis which have yet to be disclosed. Finally, policy-makers intervention can be a threat for those holding short positions.

Macro Review:

In the past few months, commodities rose significantly at a faster pace while the Dollar decelerated into all-time lows. Clearly, this is a reflection of a multi-year cycle, where investors continue to shift from paper assets to hard assets. At this point, Crude ($98), and Gold ($840) are key resistance levels. Also, watch for a recovery for the DXY (Dollar) at recent lows $74.98. Bottom-line: These relationships continue to dominate investor behavior and are reaching vital inflection points.

STOCK SPECIFIC:

Communications:

T (AT&T): Wireless revenues remain solid as company continues to generate earning growth. Stock presents attractive entry points near $39.

Technology:

SWKS (Skyworks Solutions): Uptrend intact in the past 12 months. Overall fundamentals are solid, as profit margins continue to improve. Expect consolidations and accumulate between $8-9 range.

ORCL (Oracle): Deeply oversold as stock is holding above support at $20. Despite investor anxiety on slowing IT spending, relative strength is intact.

PAYX (Paychex): Following a 4+ month of price decline, stock is nearing at a buy point at $38.

PLT (Plantronics): Appealing entry point near $26 range. Product demand expected to receive positive response in Europe and a play on office wireless growth.

HTCH (Hutchinson Tech): Long-term technical outlook is rather tempting for buyers. Last week, company confirmed its solid earnings and promising outlook create a buying opportunity as trend continues to emerge.

Healthcare:

JNJ (Johnson & Johnson): Illustrating further signs of sustainable upside move. Accumulate on pullbacks near $66.

CVTX (CV Therapeutics): Bottoming at current levels near $9. Companies top product showcasing positive sales outlook.

Consumer Staples:

ADM (Archer Daniels): Investor demand for agricultural commodities should bode well for the stock. Accumulate on pullbacks with $35 as a key support level.

Market Review: 11-12-2007

Weekly Results:

S&P 500 -3.6%, NASDAQ -6.41%, DJIA -4.01% and MSCI Emerging Markets -3.28%

Last week, sellers took full charge driving indexes lower while increasing "fear" in the marketplace. S&P 500 marked its all-time highs on October 11. Since that period, the index has given up its gains and now is back to August levels. Of course, market indexes were overbought following a strong upside move from summer lows.

Despite anxious reactions and growing uncertainty there are opportunities for long-term investors. A stock specific approach can create buying opportunities on pullbacks. A broad market decline spooked investors primarily by negative news in the Financial Services. At this point, talks of "credit crisis" and a bullish uptrend are poised for short term pauses.

Sentiment:

Fear is taking hold. Clearly, the bearish sentiment rose at a significant pace. For example, AAII Bearish Index rose by 41% during the heavy week of sell-offs. Also, Volatility climbed by 23% as the VIX (CBOE Volatility Index) reached 28.50.

Clearly, there are downside catalysts such as slowing economy, weak consumer spending and yet, the further unraveling of financial services. Not to mention, escalating macro concerns froma weaker Dollar to uncontrollable geopolitical events. All these factors contribute for headline materials but don't necessarily resolve the challenges for those seeking profitable investments.

Looking ahead:

Given an increase in selling pressure, some value is being heavily discounted. Especially, in areas not related to Energy, China, and Emerging markets. For example, neglected groups in the US such as Communication, Networkers, Telco and Media can provide bargains for those willing to jump in early. Similarly, from a sector basis, Healthcare can offer sustainable opportunity for a 1-2 year range.

Credit Risks:

Credit crisis continues to linger and more downside/bad news is not out of the question. The weakness in Financials has materialized this year as participants agree that this cycle is topping. Some lenders and banks are bound to face fundamental pressure. Intervention by policymakers along with short-term bounces are not out of the question. Nonetheless, expect stabilization in investor sentiment and fundamentals especially at this point of the business cycle.

MACRO LEVELS:

Crude: Extended in the near-term with resistance at $98.10. The commodity is up more than 40% since August 22 lows.

Gold: Few points away from all-time highs reached in 1980. Gold is far removed from its 200 day moving average. (21%), which suggests sharp short-term declines.

US 10 Year Yield: Approaching key support level at 4.20%. Attempting to bottom after a 20% decline from June highs. Similarly, Yields declined sharply in the second half of 2006 and bottomed in the fourth quarter. Let's see if a similar pattern develops at current levels.

US Dollar (DXY): Yet again all-time lows reached on Friday. Downtrend intact with no signs of bottoming.

Natural Gas: Pausing after a strong run from $5.50 to $8.66. Long-term data suggests a favorable upside potential.

STOCK SPECIFIC IDEAS:

Consumer Staples:

ADM (Archer Daniels): Strength developing from recent lows. Companies strength in corn and soybean processing should offer promising returns. Accumulate near $38-36 range.

Healthcare:

CVTX (CV Therapeutics): Sales growth combined with cost cutting sets the stage for positive moves. Growing product mix can elevate revenues for next year. Strong buy point near $9 level.

Media:

DTV (Direct TV): Leadership intact. Add on any near-term pullbacks. Notably, growth in Latin America along with expanding cost structure can create further growth.

Technology:

HTCH (Hutchinson Tech): Positive fundamentals given recent margin improvements and expectations of a profitable quarter. (Q4). Trend remains positive above $25.

BRCM (Broadcom): Deeply oversold and approaching key support levels at $30. Attractive entry point given its promising fundamentals. Although stock recently disappointed, important to note that revenue is growing and core business remains solid.

FFIV (F5 Networks): Buy point near $32-34. Global growth intact as reflected in recent earnings and appealing product cycle heading into 2008.

Market Review - 11/05/2007

There are numerous headline concerns ranging from high commodity prices to slowing economy and pessimism fueled by credit concerns. Similarly, there is a growing fear in the marketplace. Plenty of pundits continue to address worrisome issues. At one point this week, the ratio of analyst downgrade to upgrade stood at 3:1. Put/Call ratio increased as well, signaling an increase in negative sentiment.

Weakness in Financials, once again remains a dominant theme among participants. Following tremendous strength in the past few years, the current environment is least favorable from a business cycle perspective. Clearly, the sector underperformed and fundamentals are deteriorating. Although additional bad news lingers, stocks are becoming deeply oversold in the near-term.

Federal Reserve rate cuts sparked only a short-lived market reaction. Interestingly, the rate cut announcement received a tame response. Let's not forget, the $41 billion temporary reserve added to the US banking system last Thursday. Yet another example of Federal Reserves attempt to create liquidity with hopes of stabilizing credit risks.

Finally, most institutions closed their books on the year and sold their losing positions for tax purposes. Perhaps, this contributed to additional selling pressure resulting in a negative finish for the broader markets. (S&P -1.67%, Dow Jones -1.53% and Russell 2000 -2.87%).

Investment Strategy:

For those seeking to protect or grow wealth in the stock market, a systematic approach is much needed. At least one way to examine ideas is to review actionable global themes. Another approach is to make stock specific bets despite an eventful macro backdrop. Ideally, a balance of both can produce fruitful returns. In addition, investor psychology, seasonality and momentum are vital as well. The challenge is to construct a winning portfolio given the growing variables in the marketplace. On that note, here is a chart of sector allocation and stock specific ideas examined below.

Long: Technology (35%) and Healthcare (25%). Short: Financials (15%) and Energy (15%).

Technology:

Sector continues to work while displaying market leadership. Large Cap Growth Technology is an area of interest. Fundamentals remain strong for companies such as Microsoft, Cisco, Oracle and Intel. This sets a positive tone attracting investors towards the sector. These specific companies present further upside potential especially for longer-term investors. Of course, Google, Research In Motion and Apple have been the big winners, but at this point expect participation from other areas.

For broad sector exposure, consider the following funds:

QQQQ (Nasdaq 100 Trust Shares), IGM (Goldman Sachs Technology Index), XLK (S&P Technology),and MTK (Morgan Stanley Technology Index).

Technology Ideas:

SWKS (Skyworks): Improving margins and emerging strength bode well for this wireless chip maker. Buy point near $8.50-9 levels.

FFIV (F5 Networks): Appealing entry point above $34. Company should benefit from increasing demand for its advanced products as we approach an upgrade cycle in technology.

FDRY (Foundry Networks): After consolidating for 6+ years, company is benefiting from an increasing need for greater bandwidth. As a leader in its market, FDRY presents a sustainable growth. Look for near-term pullbacks as opportunity to buy.

Healthcare:

On a relative basis, several opportunities for those seeking a turn around in Pharmaceutical companies. For example, PPH (Pharmaceutical Holders Trust) is up 21% after bottoming in the summer of 2006. Also, on a stock specific basis, select names in Biotech and Medical Technology are favorable.

Healthcare Ideas:

SSRX (3SBIO Inc): A leading Chinese biotech company that remains profitable and a leader in its group. Given the 20% industry growth, 3SBIO presents attractive entry point despite near-term volatility.

ECLP (Eclipsys Corp): Attractive earnings and revenue growth for this healthcare software provider. Stabling around $25 and positive momentum remains intact.

CVTX (CV Therapeutics): Multi-month consolidation around $9-10 range. Promising product mix should contribute for an upside move from current levels.

Consumer Staples:

CQB (Chiquita Brands): Bottoming between $16-18 range. Timely entry point given managements revamped plans.

Market Observations - 10-29-2007

Weekly Results:

S&P +2.1%, NASDAQ +2.9%, Dow Jones +2.1 % Russell 2000 +2.8%, and MSCI Emerging Markets +4.95%.

Investment tactics:

Large cap growth remains a favorable area in US markets. Primarily, driven by Technology and Healthcare. At the same time, most 'value' related stocks are mostly in the struggling financial services. Participants are seeking new growth areas, as appetites shift away from commodity based and emerging markets themes. In the upcoming months, expect higher investor demand for quality and 'debt-free' companies.

In looking ahead, stock specific selection is critical at times of uncertainty. Theme based investment is relatively difficult given the various data points from earnings season and speculation on economic outlook. Nevertheless, long-term cycle favors a rotation into Technology, select Healthcare and "cash rich" companies.

Sentiment:

Overall there is general fear in the marketplace and signs of selling pressure. Relatively less fear than the previous week as put/call ratio declined to .81 and VIX (Volatility index) fell 14%. Meanwhile, percentage of bears, according to AAII rose by 35%. Mixed data indeed, but mostly bearish.

Credit Risks:

Financial companies unraveled additional weakness on their underlying balance sheets. Most news seems priced-in although fundamental weakness is difficult to ignore. That said, year-to-date shorting Financials has been profitable. At this point, an oversold bounce appears inevitable for most groups in the sector. Pending interest rate cuts can fuel a temporary recovery but sustainability remains doubtful.

Macro Takeaway:

In short, hard assets maintain their upside move as paper assets decline.

This showcases the multi-year trend of higher crude prices and lower US dollar. And in recent weeks, this trend has widened. An inverse relationship, that plays a significant role in global markets. Any directional shift should create volatility, since consensus strongly agrees with current behaviors. Although, betting against rising crude/lower dollar has not paid-off throughout the year, the odds of a reversal are yet favorable.

In terms of paper assets, Dollar recovery has not materialized. Expect early signs of bottoming as we approach year-end. A catalyst for a recovering Dollar includes actions from the European Central Banks. Primarily, a slowing economy in Europe can lower interest rates in the region. Eventually, this benefits the US Dollar on a relative basis as the Euro declines. Rather early but worth watching.

Macro Levels:

Crude: Next key resistance level is $92. That's the intra-day high from Friday. Momentum is extended from a near and long term view. Support levels include $85, then $80 (near 50 day moving average).

Chakib Khelil, Algerian energy minister, said: "The high prices are not coming from a lack of production." Venezuela echoed those comments. Financial Times 10-26-2007.

Gold: Stretched in the short-term. Next resistance is $850, all-time highs reached in 1980.

US 10 Year Yield: Attempting to bottom at 4.40%. Current trading range is in-line, with 4 + year moving average.

S&P 500: Holding above 1500 level, as index attempting to stabilize. Few points removed from all-time highs set on October 11 (1576). Expect consolidation between 1500-1540.

FXI (China 25 Index): October 17^th highs, ($218) is a key level for the index. Upside momentum is weakening. Index attempts to stabilize and retrace towards "rational" levels.

EEM (MSCI Emerging Markets Fund): Since August lows, index has spiked above 45%. Long-term data appears extended as optimism continues.

Stock Specific:

Healthcare:

MATK (Martek Bio): Bottoming with upside promises. Increasing revenue and launch of new products (includes a product to lower cholesterol) should continue the upside momentum. Technically, charts suggest an attractive entry point between $28-30 range.

CVTX (CV Therapeutics): Bottoming around $9, following a 3+ month consolidation.

SSRX (3SBIO): Leading Chinese biotech and company continues to increase its market share. Attractive entry point at $16.

Technology:

PAY ( VeriFone Inc): Solid fundamentals with positive momentum. Company continues to expand its leadership in wireless payment services.

MOT (Motorola): Showing strength following a 25% gain in the past three months. Strong base around $18.50/18. As analyst raise targets, shares remain attractive for next few quarters.

ORCL (Oracle): Appealing entry point near $20-22 range. Strong fundamentals with growth in software sales and revenues.

Consumer Staples:

CQB (Chiquita Brands): An agricultural theme that's poised for a turnaround. Buy point between $14-18 range and showing signs of bottoming.

Media:

DTV (Direct TV): Leadership intact in an emerging sector. Breaking out above $26 with appealing fundamentals.

Telecommunications:

VZ: (Verizon): Holding above $44, uptrend momentum in place. Any price declines can create buying opportunity.